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Abstract
The prospect of manipulating endogenous neural stem cells to
replace damaged tissue and correct functional deficits offers a
novel mechanism for treating a variety of CNS disorders. The
aim of this study was to investigate pathways controlling
neurite outgrowth in human neural precursor cells, in partic-
ular in response to platelet-derived growth factor (PDGF).
PDGF-AA, -AB and -BB were found to initiate calcium sig-
nalling and produce robust increases in neurite outgrowth.
PDGF-induced outgrowth of Tuj1-positive precursors was
abolished by the addition of EGTA, suggesting that calcium
entry is a critical part of the signalling pathway. Wortmannin
and PD098059 failed to inhibit PDGF-induced outgrowth.
Clostridium Toxin B increased the amount of PDGF-induced
neurite branching but had no effect on basal levels. In con-
trast, WHI-P154, an inhibitor of Janus protein tyrosine kinase
(JAK3), Hck and Syk, prevented PDGF-induced neurite out-
growth. PDGF activates multiple signalling pathways with
considerable potential for cross-talk. This study has highligh-
ted the complexity of the pathways leading to neurite out-
growth in human neural precursors, and provided initial
evidence to suggest that calcium entry is critical in producing
the morphological changes observed.
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The application of human neural stem cells to CNS drug
research offers an opportunity to develop in vitro cultures
containing a mixture of neuronal, glial and astrocytic cell
types which may provide a better reflection of the human
brain than traditional recombinant cell lines (Simpson 2005).
Such stem cell-derived cultures can be used to investigate
signalling pathways relevant to a variety of disease states. In
addition, identification of neural stem cells in the adult brain
has led to increasing interest in the potential of using stem
cells to treat CNS disorders, either by transplantation or
manipulation of endogenous stem cells (for reviews see
Mitchell et al. 2004; Zhu et al. 2005).
Whilst a large amount of work has focused on stem cell
transplantation, less is known about the potential of stimu-
lating endogenous stem cells to compensate losses of neural
cells by injury or disease. Stem cells are known to divide,
migrate and differentiate following injury to the adult brain
(Magavi and Macklis 2002; Felling and Levison 2003), but
they are unable to fully replace damaged tissue and correct
functional deficits in normal circumstances. However, the
potential to augment this endogenous response offers a novel
mechanism for treating a variety of CNS disorders without
many of the practical and ethical issues surrounding trans-
plantation-based therapeutic strategies.
Five isoforms of platelet-derived growth factor (PDGF)
have been identified to date: AA, AB and BB are formed by
dimerization of A and B chains whilst the newer members,
CC and DD, are secreted as inactive forms and less is known
about their ability to dimerize (Tallquist and Kazlauskas
Received August 25, 2005; revised manuscript received November 1,
2005; accepted November 22, 2005.
Address correspondence and reprint requests to Gillian Richards, The
Neuroscience Research Centre, Merck Sharp and Dohme Research Labor-
atories, Terlings Park, Eastwick Road, Harlow, Essex CM20 2QR, UK.
E-mail: gillian_richards@merck.com
Abbreviations used: CNTF, ciliary neurotrophic factor; CREB, cyclic-
AMP responsive binding element protein; DMEM, Dulbecco’s modified
Eagle’s medium; FGF, fibroblast growth factor; GFAP, glial fibrillary
acidic protein; JAK, Janus protein tyrosine kinase; MAPK, mitogen acti-
vated protein kinase; PBS, phosphate-buffered saline; PDGF, platelet-
derived growth factor; PI3K, phosphatidylinositol 3¢-kinase; PLC,
phospholipase C; VIPRII, voltage-ion probe reader.
Journal of Neurochemistry, 2006, 97, 201–210 doi:10.1111/j.1471-4159.2006.03723.x
 2006 Merck & Co., Inc., Whitehouse Station, NJ, USA, J. Neurochem. (2006) 97, 201–210 201
2004). Two PDGF receptors have been identified, a and b,
which belong to the tyrosine kinase receptor family. PDGF
binds to two receptors simultaneously, thus causing dimeri-
zation and tyrosine kinase activation. The a-receptor can
bind both A and B chains, whilst the b-receptor binds only B
chains (Heldin and Westermark 1999). Therefore, PDGF-AA
can only activate a homodimers, PDGF-AB activates a
homodimers or ab heterodimers, and PDGF-BB has the
broadest activity, producing aa, ab or bb dimers.
We have established in vitro human neural precursor
cultures, suitable for drug discovery, from a commercial
source of human neural precursors (Richards et al. 2004).
This study describes a number of assays which have been
developed to study cell morphology and signalling, and
characterizes the signalling pathway underlying the response
to a key neural growth factor, PDGF, in detail. In combina-
tion with other quantitative approaches for screening stem
cell biology events (Richards et al. 2004), the studies
performed here provide a model for the use of neural stem/
precursor cells, and their progeny, within neuroscience drug
discovery (Simpson 2005).
Methods
Cell culture
Human neural precursors were obtained from a commercial source
(Batch no. 8F0389; Clonetics, Cambrex, East Rutherford, NJ, USA).
According to the manufacturer’s information, the neural precursor
cells were obtained from cortical tissue from a female donor of
17 weeks gestation. Cells were supplied as neurospheres, charac-
teristic of the cells produced by the methodology of Svendsen et al.
(1998). Cells were grown as neurospheres in Dulbecco’s modified
Eagle’s medium (DMEM; Sigma-Aldrich, Poole, UK)/F12 (Invitro-
gen Life Technologies, Paisley, UK) 3 : 1, 1% N2 (Invitrogen Life
Technologies), epidermal growth factor (EGF) 20 ng/mL (Pepro-
tech, London, UK) and leukemia inhibitory factor (LIF) 10 ng/mL
(Chemicon, Chandlers Ford, Hampshire, UK), largely as previously
described (Richards et al. 2004). Neurospheres were passaged every
2 weeks by chopping into quarters using a tissue chopper (Mickle
Laboratory Engineering, Guildford, UK). Cells were thawed at
passage 3 and were discarded after passage 20. Cells were prepared
for plating 7–12 days post-chopping by Accutase (Innovative Cell
Technologies, San Diego, CA, USA) dissociation. Briefly, this
entailed washing neurospheres three times in phosphate-buffered
saline (PBS, Sigma-Aldrich), adding 3 mL Accutase, diluted 1 : 5
with Hanks balanced salt solution (Invitrogen Life Technologies)
and shaking for 30 min in a shaker-incubator at 37C; 7 mL PBS
were added, followed by trituration in a 10 mL pipette. Cells were
harvested by centrifugation at 150 g for 5 min and resuspended in
standard plating medium [DMEM/F12 3 : 1, transferrin 50 lg/mL
(Merck Biosciences, Nottingham, UK)/insulin 5 lg/mL/progester-
one 20 nM/putrescine 100 lM/T3 30 nM/selenium 30 nM (all from
Sigma-Aldrich)] with further trituration. For microplate-based
experiments, cells were plated at 17 500 cells per well in 96-well,
black-sided, microtitre poly D-lysine-coated plates (Biocoat, BD
Biosciences, Oxford, UK) coated with laminin 1 lg/mL (Sigma).
For single cell calcium imaging studies, cells were plated, at
500 000 cells per well, in 6-well plates with a 22 mm glass
coverslip coated with poly D-lysine and laminin in each well.
Culture characterization
Cells were plated in 96-well plates as described above. Cultures
were maintained for varying periods of time, then fixed in ice-cold
methanol for 3 min, washed three times in PBS, and blocked and
permeabilized for 1 h with 5% normal goat serum/1% bovine serum
albumin (BSA)/0.1% Triton-X 100 in PBS (all from Sigma-
Aldrich). Immunofluorescence staining was performed using pri-
mary antibodies for 1 h at 25C, and secondary antibodies and
nuclear counterstain for 1 h at 25C. Primary antibodies included
1 : 500 monoclonal anti-b3 tubulin (‘Tuj1’; Covance, Cambridge
Bioscience, Cambridge, UK), 1 : 200 polyclonal anti-nestin (Chem-
icon) and 1 : 1000 monoclonal anti-glial fibrillary acidic protein
(GFAP) (Sigma-Aldrich). Alexa 488-conjugated goat anti-mouse
secondary antibodies (1 : 500; Invitrogen Life Technologies) were
used in conjunction with 30 lM Hoechst 33342. Cell counting was
performed in an automated manner using a Cellomics ArrayScan II
(Cellomics, Pittsburgh, PA, USA).
Neurite outgrowth
Growth factors were added to cells 1 h post-plating and incubated
for 48 h at 37C/5% CO2. For mechanistic studies, inhibitors were
added to cells 1 h post-plating, and PDGF-AB added following
10 min of incubation. Cell plates were then incubated for 48 h at
37C/5% CO2. Growth factors studied were PDGF-AA, -AB and -
BB (all from Peprotech EC), ciliary neurotrophic factor (CNTF),
acidic fibroblast growth factor (FGF) and basic FGF (all from Merck
Biosciences). The inhibitors used were 30 lM WHI-P154, 50 nM
wortmannin, 200 pg/mL Clostridium difficile Toxin B (all from
Merck Biosciences) and 50 lM PD098059 (Sigma-Aldrich). Fol-
lowing incubation, cells were fixed in ice-cold methanol for 3 min,
washed three times in PBS, and blocked and permeabilized for 1 h
with 5% normal goat serum/1% BSA/0.1% Triton-X 100 in PBS (all
from Sigma-Aldrich). Immunofluorescence staining was performed
as described above.
A Cellomics ArrayScan II was used to automatically quantify
process outgrowth as previously described (Simpson et al. 2001;
Arden et al. 2002; Ramos Villullas et al. 2003). The ArrayScan
automatically captures images of labelled nuclei and cellular
processes, and applies an algorithm to measure process number,
length and complexity. This protocol detects outgrowth from the
human neural cell culture (Fig. 2a1–3). In this study, data are shown
from two primary algorithm outputs (outgrowth index and form
factor) and a daughter parameter derived from other algorithm
outputs (average process length per cell). Outgrowth index indicates
the percentage of cell with process lengths greater than the threshold
level, and form factor provides an indication of the extent of process
branching. In combination, these three parameters provide a robust
indication of cell morphology.
Well-based microplate calcium imaging
Cells were washed with physiological salt solution (KHB: NaCl
118 mM, KCl 4.7 mM, NaHCO3 4.2 mM, KH2PO4 1.2 mM, CaCl2
1.3 mM, MgSO4 1.2 mM, HEPES 10 mM; all from Sigma-Aldrich)
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and incubated with 5 lM fluo-3AM/0.004% pluronic acid (Molecu-
lar Probes) for 1 h at 25C. Following incubation, cells were washed
three times in KHB and transferred to a voltage-ion probe reader
(VIPRII; Aurora Discovery, San Diego, CA, USA) for compound
addition and recording. Data were analysed using an in-house
custom data analysis solution. Background fluorescence values were
subtracted from the raw fluorescence values, which were then
normalized to basal fluorescence. Data are hence expressed as
‘change in fluorescence over basal’ or DF/F.
Single-cell calcium imaging
Coverslips of cells were transferred to 35 mm dishes, washed in KHB
three times and incubatedwith 5 lM fura-2AM (Molecular Probes) for
45 min in the dark at 25C. Following incubation, coverslips were
washed and transferred to an imaging system comprising an inverted
microscope (Nikon, Kingston upon Thames, Surrey, UK), rapid
solution changer (BioLogic, Claix, France), Deltaram excitation
source, ICCD camera and IMAGEMASTER software (all supplied by
Photon Technology International, Birmingham, NJ, USA). For some
experiments, after recording PDGF responses, cells were processed
for immunofluorescence in situ, using identical fixing and staining
protocols as described above. Data were analysed in IMAGEMASTER
using a macro to ratio the 340 nm : 520 nm and 380 nm : 520 nm
images, followed by an in-house custom-designed data analysis
solution to express data as ‘change in fluorescence over basal’ orDF/F.
Cell-based microplate calcium imaging
Cells were washed with KHB three times and incubated with 5 lM
fluo-3AM/0.004% pluronic acid (Molecular Probes) for 1 h at 25C.
Following incubation, cells were washed three times in KHB, and
transferred to a BD Pathway HT (BD Biosciences) plate imager for
compound addition and image collection. After recording PDGF
responses, cell plates were processed for immunofluorescence using
fixing and staining protocols identical to those described above. Cell
plates were returned to the BD Pathway HT for identification of the
subpopulations of cells imaged in the kinetic experiments. Data
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Fig. 1 Human neural precursors were plated, cultured and processed
for immunofluorescence labelling experiments. Cells were dual
labelled for (a) GFAP (red) and nestin (green) with dual labelling
appearing in yellow, (b) Tuj1 (red) and nestin (green), and (c) GFAP
(green) and Tuj1 (red). Nuclei are indicated in blue. (d) The proportion
of GFAP+ cells decreased over a 15 day culture period, whereas the
Tuj1+ cells increased to approximately 15% of the total cell population.
n ¼ 7 wells; error bars indicate standard error.
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were analysed using an in-house custom data analysis solution to
express data as ‘change in fluorescence over basal’ or DF/F, and to
quantify the amplitude, delay and area under the curve for PDGF
calcium responses.
Statistics
Statistical analysis was performed using unpaired t-tests or one-way
analysis of variance, as appropriate, within GraphPad Prism
(GraphPad Software, San Diego, CA, USA).
Results
Cell culture characterization
Initial immunofluorescence labelling experiments were per-
formed on cultured human neural cells derived from
neurospheres. At 48 h after plating, a large proportion of
the cells were positive for nestin, a marker for neural
progenitor cells (Figs 1a and b, green-labelled cells). An
overlapping subpopulation of these cells also labelled
positive for GFAP, a marker for astrocytes (Fig. 1a, yellow
labelling). A non-overlapping subpopulation of cells was
found to express Tuj1, an early neuronal marker (Fig. 1b).
No overlap in GFAP and Tuj1 labelling was observed
(Fig. 1c). The proportion of GFAP- and Tuj1-positive cells in
the cultures was followed over a 15 day culture period. Over
this time course, initially approximately 25% of cells were
GFAP+, decreasing to less than 5% at 15 days. The
proportion of Tuj1+ cells increased from less than 5% to
between 10 and 15% at 15 days (Fig. 1d). The cell cultures
were examined for expression of a number of oligodendro-
cyte markers including O4, galactocerebroside C and myelin
basic protein, none of which were found to be expressed
(data not shown).
Differential effects of growth factors on neural cell
process outgrowth
Following this immunocytochemical characterization of the
cultures, we examined which growth factors would alter the
morphology of the human neural cells. PDGF-AA, -AB and
-BB induced a robust increase in outgrowth index in Tuj1-
labelled neural cells in a concentration-dependent manner,
following a 48 h incubation (PDGF-AA EC50 ¼ 4.7 ±
1.2 ng/mL; PDGF-AB EC50 ¼ 9.7 ± 7.0 ng/mL; PDGF-
BB EC50 ¼ 6.0 ± 0.9 ng/mL; maximal effects observed at
300 ng/mL: see Fig. 2b1–3). Corresponding increases in
process complexity and length were also observed. Moderate
outgrowth effects were elicited by bFGF, whilst aFGF and
CNTF were without substantial effects on cellular process
outgrowth (Fig. 2bi–iii). PDGF elicited process extension in
multiple cell types within the human culture system: the
magnitude of effect of 100 ng/mL PDGF-AB was similar in
both the Tuj1- (neuronal) and GFAP-labelled subpopulations
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Fig. 2 (a) Cellomics ArrayScan automatically captures images of
labelled nuclei (i) and cellular processes (ii), and a user-defined
algorithm measures process number, length and complexity. The blue
overlay indicates objects identified as nuclei on the basis of Hoechst
33342 labelling, and the green overlay indicates processes identified
using anti-bIII tubulin primary antibody (Tuj1) and Alexa-488 conju-
gated secondary antibody. (b) PDGF-AA, -AB and -BB induce out-
growth in Tuj1-labelled cells, with increases in complexity and length of
processes. Moderate outgrowth effects were elicited by bFGF, whilst
aFGF and CNTF were without substantial effects. n ¼ 5 separate
experiments. The magnitude of effect was similar for all three PDGF
isoforms.
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(Figs 3a–c, p > 0.05 for all parameters). Data are expres-
sed as fold-change over basal to allow for the observation
that the GFAP-labelled cells tended to show higher abso-
lute outgrowth values under both basal and stimulated
conditions.
PDGF isoforms increase neural intracellular calcium
We have previously reported that PDGF is an effective
activator of chemotaxis but not chemokinesis in this neural
population, and that intracellular calcium, but not mitogen-
activated protein kinase (MAPK), is an important regulator
for chemotactic responsiveness (Richards et al. 2004). In
order to begin to elucidate the signalling mechanisms
underlying PDGF-induced outgrowth in human neural
precursor cells, experiments were performed to determine
the effects of PDGF on intracellular calcium levels. Using a
VIPRII plate reader, 100 ng/mL of each of the three isoforms
of PDGF tested evoked an increase in intracellular calcium in
the human neural precursor population. The magnitude of
response did not significantly vary from 1 day to 7 days in
culture (Fig. 4a).
Single-cell imaging was then performed with a micro-
scope-based imaging set-up to investigate the PDGF-induced
calcium responses of the Tuj1-positive subpopulation
(approximately one-third of the cells within the population).
Within the Tuj1-positive subpopulations, approximately one-
third of cells responded to PDGF with a calcium elevation,
whereas within the Tuj1-negative population, more than half
of the cells responded (Fig. 4b). Single-cell responses were
characterized further using a BD Pathway HT imaging
system. Using this technique, the peak calcium response to
PDGF-AB had an EC50 of 2.33 ± 1.3 ng/mL, and the area
under the curve had an EC50 of 2.58 ± 1.6 ng/mL (mean data
from n ¼ 3 experiments; greater than 20 cells per experi-
ment; see Figs 5a and b). Calcium responses in subpopula-
tions of the cell culture were studied by performing post hoc
immunolabelling. For the three different subpopulations
studied, all showed typical peak-plateau profiles (Fig. 6a),
and [Ca2+]i remained elevated for > 400 s. The peak ampli-
tude and area under the curve of calcium responses to PDGF
appears higher for nestin- and GFAP-positive cells than for
Tuj1-positive cells (Fig. 6bi and ii; n ¼ 37 GFAP+, 47
nestin+ and 9 Tuj1+ cells). However, the heterogeneity of the
cell cultures is such that low numbers of Tuj1+ cells were
included in this experiment and hence, it is not possible to
conclude whether this represents a robust, statistically
significant difference.
The PDGF-stimulated process outgrowth signalling
pathway
A wide range of signalling cascades has been shown to be
initiated following PDGF-receptor activation, with different
pathways involved in multiple effects depending on cell type,
cell cycle and duration of PDGF exposure (for reviews see
Heldin and Westermark 1999; Tallquist and Kazlauskas
2004). Among the more well characterized effectors
are phospholipase C (PLC)/calcium, phosphatidylinositol
3¢-kinase (PI3K), cyclic-AMP responsive binding element
protein (CREB), Src, MAPK and JAK/Stat. The mechanism
of action of PDGF-stimulated process outgrowth in the Tuj1-
positive subpopulation was investigated by incubating cells
with 100 ng/mL PDGF-AB in the presence and absence of
various cell signalling inhibitors.
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Fig. 3 100 ng/mL PDGF-AB induces similar magnitude increases in
(a) outgrowth index, (b) complexity and (c) length of processes in
GFAP-, Tuj1- and nestin-labelled cells (n ¼ 3 separate experiments).
Data are expressed as fold-change over basal.
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Chelation of extracellular calcium by incubation with
2 mM EGTA abolished outgrowth responses to PDGF-AB in
Tuj-1-positive cells. (Figs 7a–c). Similarly, co-application of
PDGF with the JAK-3 inhibitor, WHI-P154 (30 lM), abol-
ished PDGF-AB-induced increases in outgrowth index,
process branching and process length. (p < 0.05, Figs 7a–c).
WHI-P154 also produced a small inhibition of basal
outgrowth and process length (p < 0.05, Figs 7d–f). In
contrast, co-application of PDGF and Clostridium Toxin B
(200 pg/mL), a selective inhibitor of Rho, Rac and Cdc-42
small GTPases, produced a small but significant increase in
branching compared with PDGF alone (p < 0.05, Fig. 7b),
whereas it had no effect on basal outgrowth (Figs 7d–f).
PD098059 (50 lM), an inhibitor of MAPk kinase (Dudley
et al. 1995), and 50 nM wortmannin, an inhibitor of PI3K
(Yano et al. 1993), were without significant effects on either
basal or PDGF-stimulated outgrowth (p > 0.05, Figs 7a–f).
Discussion
Neurite outgrowth is thought to be a key step in the
pathway from precursor to differentiated neurone (Tojima
and Ito 2004), and for establishing new synaptic contacts
(Niell et al. 2004). In this study, a number of growth factors
were investigated for their ability to produce changes in
process outgrowth in human neural precursor cells. PDGF-
AA, -AB and -BB were seen to produce robust increases in
outgrowth in Tuj1-positive cells, not only increasing the
proportion of cells with processes, but also eliciting
increases in process length and complexity. Moderate
outgrowth effects were elicited by bFGF, whilst aFGF and
CNTF were without substantial effects in these cells.
PDGF-AB was also seen to elicit process outgrowth in
GFAP- and nestin-positive cells.
The importance of PDGF in oligodendrocyte proliferation
and differentiation is widely accepted. PDGF has also been
shown to induce neurite outgrowth in a variety of in vitro
neuronal systems, including fetal rat and human dopamin-
ergic neurones (Othberg et al. 1995), SHSY5Y cells (Hynds
et al. 1997) and hippocampal HiB5 cells (Sung et al. 2001).
We have previously found that PDGF increases motility in
human neural precursor cells (Richards et al. 2004). PDGF-
AA can only activate a PDGF receptor homodimers,
PDGF-AB activates a homodimers or ab heterodimers, and
PDGF-BB has the broadest activity, producing aa, ab or bb
dimers. In this study, PDGF-AA, -AB and -BB all produced
similar effects on outgrowth, suggesting that receptor
subtype-specific effects are not present, or not detectable,
in our experimental system. However, it is possible that
receptor expression and hence, isoform-specific effects,
change during differentiation as has previously been shown
(Erlandsson et al. 2001).
(b)
(a)
Fig. 4 (a) Calcium responses to 100 ng/mL PDGF were recorded
using a VIPRII plate reader. Human neural precursors were studied
1–7 days following plating. The magnitude of PDGF-evoked re-
sponses did not vary with time between isoforms. Data are expressed
as the change in fluorescence over basal (DF/F) (n ¼ 3). (b) Single-
cell calcium responses to PDGF-AB were measured using a micro-
scope-based imaging system, with post hoc immunolabelling to iden-
tify cell types. Approximately one-third of Tuj1-positive cells responded
with a calcium elevation, whereas more than half of the Tuj1-negative
cells responded. Data are expressed as a percentage of the total
number of cells studied (n ¼ 154 cells).
206 G. R. Richards et al.
 2006 Merck & Co., Inc., Whitehouse Station, NJ, USA, J. Neurochem. (2006) 97, 201–210
Multiple signalling cascades are initiated following PDGF-
receptor activation (Heldin and Westermark 1999; Tallquist
and Kazlauskas 2004). Considerable cross-talk may occur
between pathways, and this work has begun to elucidate
which are important in PDGF-stimulated neurite outgrowth
in Tuj1-positive human neural precursors. Previous studies
with hippocampal HiB5 cells showed that phospholipase C
(PLC) activation was critical for PDGF-induced neurite
outgrowth in these cells (Sung et al. 2001). Activation of
PLC produces an increase in intracellular calcium and
activation of protein kinase C. All three isoforms of PDGF
elicited an increase in intracellular calcium in subpopulations
of human neuronal and non-neuronal cells, and single-cell
studies showed that approximately 30% of cells positive for
the neuronal pathway marker, Tuj1, responded. Additionally,
100 ng/mL PDGF-AB produces approximately a 30%
increase in outgrowth index compared with basal levels,
that is, approximately 30% of Tuj1-positive cells show
increased outgrowth above basal levels. Whilst the experi-
ments performed here cannot prove a direct correlation, the
EC50 values observed for outgrowth and calcium entry were
also in a similar range, suggesting that this may be a critical
step in initiating outgrowth. Increased intracellular calcium
has been implicated in promoting neurite outgrowth and
growth cone guidance in a number of experimental systems
(Lohmann et al. 2002; Borodinsky et al. 2003; Wang and
Poo 2005), although it may also have a role in growth cone
stalling in other circumstances (Lautermilch and Spitzer
2000). Addition of EGTA to the extracellular medium
abolished PDGF-induced outgrowth in Tuj1+ cells, suggest-
ing that an increase in intracellular calcium, more specific-
ally, calcium influx, is critical for this pathway. With
time-lapse experiments, it may be possible to directly
correlate the initial calcium response with any subsequent
morphological changes and cell phenotype. In this study, we
have focused on the signalling pathways in Tuj1+ neural
cells. However, a significant proportion of the Tuj1-negative
cells responded to PDGF with increased intracellular
calcium. Nestin+ and GFAP+ cells responded to PDGF with
outgrowth and calcium influx, although the signalling
pathways were not studied further in these cell types. In
follow-up work, we are continuing to examine the mechan-
ism of PDGF-evoked calcium responses, in particular the
mechanism of calcium entry and subsequent downstream
signalling cascades in both Tuj1+ and GFAP+ cells.
PI3K and the Rho-family of small GTPases have been
reported to play important roles in neurite outgrowth and
branching (Jackson et al. 1996; Leemhuis et al. 2004).
However, in the human neural precursors, inhibition of
PI3K with wortmannin did not produce significant effects on
any aspect of basal or PDGF-stimulated outgrowth. Interest-
ingly, Clostridium Toxin B increased the amount of PDGF-
induced branching, but had no effect on basal levels.
Previous reports have suggested that Rho GTPases have
differing roles in axons and dendrites, with Cdc42 and Rac
promoting, and Rho inhibiting, dendrite branching (Leemh-
uis et al. 2004), whilst Clostridium Toxin B disrupts
neuronal polarization and produces cells with multiple axons
in rat hippocampal neurones (Bradke and Dotti 1999). The
present finding indicates a potential role for small GTPases in
mediating human neural cell outgrowth, perhaps dependent
on the stimulation applied.
The MAPK pathway is reported to be involved in neurite
outgrowth in a variety of experimental systems (Szeberenyi
et al. 1990; Cowley et al. 1994; Pang et al. 1995;
Encinas et al. 1999) and may be activated downstream of
PI3K (Pan et al. 2005) or Src (see Bromann et al. 2004 for
review). PD098059 was without effect on PDGF-stimulated
outgrowth in Tuj1-positive cells, suggesting that MAPK is
not the sole effector in human neural precursors. Further
experiments with combinations of inhibitors of pathways
thought to work in sequence or in parallel would be
necessary to confirm that PI3K and MAPK signalling are
not critical in the response to PDGF.
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Fig. 5 Calcium responses to PDGF-AB were recorded at cell level
using a BD Pathway HT imaging system. PDGF evoked a peak and
plateau response, and the EC50 was determined for (a) the peak
response (2.33 ± 1.3 ng/mL) and (b) the area under the curve
(2.58 ± 1.6 ng/mL). n ¼ 3 experiments, minimum of 20 cells per
experiment.
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Fig. 6 Calcium responses to PDGF-AB were recorded in subpopula-
tions of human neuronal precursors using a BD Pathway HT imaging
system and post hoc immunolabelling. (a) Representative calcium
traces from each cell type studied. Data are expressed as the change
in fluorescence over basal (DF/F). (b) Responses to PDGF of GFAP+,
nestin+ and Tuj1+ precursors, determined by both peak (i) and area
under the curve (ii) measurements. Data are expressed as the change
in fluorescence over basal (DF/F); only cells which produced a change
of > 1.1 were classified as responders and included in the analysis
(n ¼ 37 GFAP+, 47 nestin+ and 9 Tuj1+ cells).
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Fig. 7 The effects of various signalling pathway inhibitors on PDGF-
induced (a–c) and basal (d–f) outgrowth in human neural precursors.
The 100 ng/mL PDGF-AB-induced outgrowth is significantly inhibited
by the JAK3 inhibitor, WHI-P154, and 2 mM EGTA. (p < 0.05, n ¼ 2 or
3 experiments, minimum of 8 wells per experiment; *p < 0.05).
Abbreviations: –, basal levels; +, PDGF-AB 100 ng/mL; A,
PDGF + WHI-P154; B, PDGF + wortmannin; C, PDGF + Clostridium
Toxin B; D, PDGF + PD098059; E, PDGF + EGTA; F, WHI-P154; G,
wortmannin; H, Clostridium Toxin B; I, PD098059; and J, EGTA. All
data expressed as a percentage of the PDGF positive control response.
208 G. R. Richards et al.
 2006 Merck & Co., Inc., Whitehouse Station, NJ, USA, J. Neurochem. (2006) 97, 201–210
PDGF-induced outgrowth was inhibited by WHI-P154, a
compound which is reported to inhibit JAK3 (Ghosh et al.
1999). This raises the possibility that JAK activation occurs
upstream of calcium entry, as has been reported in mast cells
(Malaviya et al. 1999), T cells (Sa¨emann et al. 2003), and in
response to chemokines (Soriano et al. 2003). WHI-P154
also inhibits the Src-family kinase, Hck, and the non-receptor
tyrosine kinase, Syk, with similar affinity to JAK3 (Ghosh
et al. 1999). Src and Syk are thought to be activated
sequentially, and downstream targets of Syk include PLC
(Sillman and Monroe 1995), PI3K (Beitz et al. 1999) and
Vav (Deckert et al. 1996). Downstream targets of Vav trigger
cytoskeletal reorganization (Hornstein et al. 2004) and have
been implicated in axon guidance (Cowan et al. 2005). In
addition, Syk may have a role in neurite outgrowth in P19
cells in response to retinoic acid or cell-matrix attachment
(Tsujimura et al. 2001). The more selective JAK3 inhibitor,
WHI-P131, could be used to define the role of JAK in this
pathway. However, it is at least possible that the inhibitory
effect of WHI-P154 on PDGF-induced outgrowth is in fact
due to inhibition of Syk.
PDGF activates multiple signalling pathways with the
considerable potential for cross-talk. For example, the signal
transducer and activator of transcription (STAT) pathway has
been shown to interact with the MAPK pathway (Decker and
Kovarik 2000), and there is evidence for interplay between
PDGF/Src/STAT signalling (Bromann et al. 2004). This
study has highlighted the complexity of the pathways leading
to neurite outgrowth, and provided initial evidence to suggest
that calcium entry is critical in producing the morphological
changes observed.
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